Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  arsenic trioxide
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Tretinoin and Arsenic Trioxide in Treating Patients with Untreated Acute Promyelocytic Leukemia
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 12 to 21
Trial IDs: AAML1331, NCI-2014-02266, PAAML1331_A01PAMDREVW0, NCT02339740
Tretinoin and Arsenic Trioxide with or without Gemtuzumab Ozogamicin in Treating Patients with Previously Untreated Acute Myeloid Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 10 and over
Trial IDs: 2010-0981, NCI-2011-02767, NCT01409161
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: HEMAML0023, NCI-2013-00767, 26938, NCT01835288
Arsenic Trioxide and Imatinib Mesylate, Dasatinib, or Nilotinib in Treating Patients with Chronic Myelogenous Leukemia
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 11-107, NCI-2011-03292, NCT01397734
Arsenic Trioxide and Itraconazole in Treating Patients with Advanced Basal Cell Cancer
Status: Not yet active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0033, NCI-2016-00180, NCT02699723
Start Over